Fueling the future of precision medicine and targeted therapies with NGS-based companion diagnostics (companion Dx).
Illumina provides an innovative portfolio of NGS systems, products, and services for many phases of the drug development pipeline.
Leaders in translational genomics and computational biology designed an array to support earlier target selection and validation in drug development.
This is the international website for Illumina. If you are looking for information specific to your region, please select your location and we will redirect you.